Parkinson's disease
Not yet recruitingStudy of VQ-101 to Slow Progression in Adults with GBA1‑Associated Parkinson’s Disease
- Disease:Parkinson's disease
- Substances:–
France- Participants:18–64 years · 65+ years
- Sponsor:Vanqua Bio Inc.
Rare diseases
Investigational molecules
Locations
1375 West Fulton Street Suite 600, 60607-1157, United States
Research activity is centered on Parkinson’s disease, with clinical interest extending to the neurological features associated with GBA1 mutations and their relevance to disease expression.
The sponsor’s clinical focus is directed toward understanding neurodegenerative disease mechanisms within a Parkinsonian population.
Vanqua Bio Inc. runs clinical trials in conditions such as Parkinson's disease, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.